Table 1 Baseline anthropometry, duration of high altitude stay and pulmonary functions in HAPE susceptible (HAPE-S) and HAPE resistant (HAPE-R) subjects.
From: Raised HIF1α during normoxia in high altitude pulmonary edema susceptible non-mountaineers
HAPE-S (n = 11) | HAPE-R (n = 11) | ||
|---|---|---|---|
Age (Yrs) | 31.7 ± 3.3 | 29.8 ± 2.1 | NS |
Height (cm) | 168.3 ± 6 | 171.2±3.3 | NS |
Weight (Kg) | 70.7 ± 6.3 | 69.7 ± 7.8 | NS |
High altitude stay (Yrs) | ½–1 | 2 | |
FVC (Lt) | 4.3 ± 0.4 | 4.5 ± 0.4 | NS |
FVC% | 96.3 ± 13.7 | 94 ± 8.3 | NS |
FEV1 (Lt) | 3.5 ± 0.4 | 3.8 ± 0.3 | NS |
FEV1/FVC | 82.1 ± 4.8 | 84 ± 4.6 | NS |
TLC (Lt) | 6.2 ± 0.8 | 6.3 ± 0.6 | NS |
TLC% | 105.7 ± 16.7 | 100.1 ± 10.1 | NS |
FRC (Lt) | 3.2 ± 0.6 | 3.4 ± 0.6 | NS |
FRC% | 110.5 ± 20.1 | 112.3 ± 19.4 | NS |
DLCO (ml/kg/mm Hg) | 33.9 ± 6.1 | 37.3 ± 6.3 | NS |
DLCO% | 109.3 ± 21 | 114.4 ± 19.4 | NS |
VA% | 74.8 ± 8.7 | 75.9 ± 7.3 | NS |
DLCO/VA | 121.6 ± 15.9 | 124.3 ± 14.6 | NS |
